威高血净：公司目前正在推进威海、赣州厂房以及生产线建设，建成后产能将得到进一步提升

Core Viewpoint - Weigao Blood Products (603014) is actively expanding its production capacity and international presence, focusing on Southeast Asia, South America, Eastern Europe, and North Africa markets [1] Group 1: Production Capacity - The company is currently advancing the construction of factories and production lines in Weihai and Ganzhou, which will further enhance its production capacity [1] Group 2: International Expansion - Weigao Blood Products is continuously expanding its overseas business, having established subsidiaries in Ecuador and Indonesia, and plans to deepen local operations in these regions [1]